Accenture has made a strategic investment, through Accenture Ventures, in Virtonomy, a provider of data-driven simulations that use existing patient data and digital twin technology to bring life-saving medical devices to market more quickly. Accenture’s investment will help Virtonomy further extend its capabilities to medical technology companies across the globe and power the future of medical device design…For instance, Virtonomy’s solution can use existing data from clinical trials with children to create virtual environments where medical devices can be easily set up, adjusted and validated, and potential impact is seen immediately. This approach saves time and still meets regulatory and ethical demands. Based in Munich, Germany, Virtonomy comprises an interdisciplinary team of experts in medical engineering, image and data processing, visualization and clinical practice.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on ACN:
- Street Wrap: Today’s Top 15 Upgrades, Downgrades, Initiations
- Accenture upgraded to Buy from Hold at Edward Jones
- Accenture, QuSecure team in first successful multi-orbit communications link
- Accenture price target raised to $327 from $310 at BMO Capital
- Accenture price target raised to $340 from $335 at RBC Capital